- Home
- THTX vs JLS Comparison
THTX vs JLS Comparison
Compare THTX & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- JLS
- Stock Information
- Founded
- THTX 1993
- JLS 2009
- Country
- THTX Canada
- JLS United States
- Employees
- THTX N/A
- JLS N/A
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- JLS Investment Managers
- Sector
- THTX Health Care
- JLS Finance
- Exchange
- THTX Nasdaq
- JLS Nasdaq
- Market Cap
- THTX 118.2M
- JLS 97.1M
- IPO Year
- THTX N/A
- JLS N/A
- Fundamental
- Price
- THTX $2.62
- JLS $18.16
- Analyst Decision
- THTX Hold
- JLS
- Analyst Count
- THTX 1
- JLS 0
- Target Price
- THTX N/A
- JLS N/A
- AVG Volume (30 Days)
- THTX 6.2M
- JLS 26.6K
- Earning Date
- THTX 04-09-2025
- JLS 01-01-0001
- Dividend Yield
- THTX N/A
- JLS 9.33%
- EPS Growth
- THTX N/A
- JLS N/A
- EPS
- THTX N/A
- JLS N/A
- Revenue
- THTX $88,666,000.00
- JLS N/A
- Revenue This Year
- THTX N/A
- JLS N/A
- Revenue Next Year
- THTX $15.13
- JLS N/A
- P/E Ratio
- THTX N/A
- JLS N/A
- Revenue Growth
- THTX 13.52
- JLS N/A
- 52 Week Low
- THTX $1.08
- JLS $15.48
- 52 Week High
- THTX $3.13
- JLS $17.97
- Technical
- Relative Strength Index (RSI)
- THTX 57.56
- JLS 51.96
- Support Level
- THTX $2.64
- JLS $18.09
- Resistance Level
- THTX $2.82
- JLS $18.32
- Average True Range (ATR)
- THTX 0.17
- JLS 0.20
- MACD
- THTX -0.04
- JLS 0.06
- Stochastic Oscillator
- THTX 20.45
- JLS 75.71
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About JLS Nuveen Mortgage and Income Fund
Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.